Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Claessens

Showing results (61-70 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|April 11, 2024
Structural mechanism underlying variations in DNA binding by the androgen receptorXiao Yin Lee, Wout Van Eynde, Christine Helsen, et al.
European Thyroid Journal|October 17, 2024
Apalutamide-induced severe hypothyroidism: case series and practice recommendations for thyroid managementKarel David, Paul Van Crombrugge, Anne-Marie Van der Biest, et al.
Analytical and Bioanalytical Chemistry|July 30, 2013
Sensitive routine liquid chromatography-tandem mass spectrometry method for serum estradiol and estrone without derivatizationSteven Pauwels, Leen Antonio, Ivo Jans, et al.
Journal of Cellular and Molecular Medicine|July 17, 2008
The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growthMaria Papaioannou, Sonja Schleich, Ina Prade, et al.
Molecular Cancer Therapeutics|October 11, 2022
Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor InhibitorsChristine Helsen, Tien T Nguyen, Xiao Yin Lee, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 12, 2020
A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic ChemicalsAdam T Szafran, Michael J Bolt, Caroline E Obkirchner, et al.
Biomed Research International|April 5, 2014
The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision makingThomas Van den Broeck, Steven Joniau, Liesbeth Clinckemalie, et al.
Molecular Pharmacology|February 25, 2005
Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interactionGuy Eelen, Lieve Verlinden, Natacha Rochel, et al.
Cells|November 20, 2020
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate CancerWout Devlies, Markus Eckstein, Alessia Cimadamore, et al.
Molecular and Cellular Endocrinology|June 14, 2020
Androgen action on renal calcium and phosphate handling: Effects of bisphosphonate treatment and low calcium dietRougin Khalil, Ioannis Simitsidellis, Na Ri Kim, et al.
Pageof 18

Showing results (61-70 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Steroid Biochemistry and Molecular Biology|April 11, 2024
Structural mechanism underlying variations in DNA binding by the androgen receptorXiao Yin Lee, Wout Van Eynde, Christine Helsen, et al.
European Thyroid Journal|October 17, 2024
Apalutamide-induced severe hypothyroidism: case series and practice recommendations for thyroid managementKarel David, Paul Van Crombrugge, Anne-Marie Van der Biest, et al.
Analytical and Bioanalytical Chemistry|July 30, 2013
Sensitive routine liquid chromatography-tandem mass spectrometry method for serum estradiol and estrone without derivatizationSteven Pauwels, Leen Antonio, Ivo Jans, et al.
Journal of Cellular and Molecular Medicine|July 17, 2008
The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growthMaria Papaioannou, Sonja Schleich, Ina Prade, et al.
Molecular Cancer Therapeutics|October 11, 2022
Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor InhibitorsChristine Helsen, Tien T Nguyen, Xiao Yin Lee, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 12, 2020
A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic ChemicalsAdam T Szafran, Michael J Bolt, Caroline E Obkirchner, et al.
Biomed Research International|April 5, 2014
The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision makingThomas Van den Broeck, Steven Joniau, Liesbeth Clinckemalie, et al.
Molecular Pharmacology|February 25, 2005
Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interactionGuy Eelen, Lieve Verlinden, Natacha Rochel, et al.
Cells|November 20, 2020
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate CancerWout Devlies, Markus Eckstein, Alessia Cimadamore, et al.
Molecular and Cellular Endocrinology|June 14, 2020
Androgen action on renal calcium and phosphate handling: Effects of bisphosphonate treatment and low calcium dietRougin Khalil, Ioannis Simitsidellis, Na Ri Kim, et al.
Pageof 18